DK318481A - Syntetisk peptid specifik antigenisk determinant og fremgangsmaade til fremstilling af antigene meneraler deraf - Google Patents

Syntetisk peptid specifik antigenisk determinant og fremgangsmaade til fremstilling af antigene meneraler deraf

Info

Publication number
DK318481A
DK318481A DK318481A DK318481A DK318481A DK 318481 A DK318481 A DK 318481A DK 318481 A DK318481 A DK 318481A DK 318481 A DK318481 A DK 318481A DK 318481 A DK318481 A DK 318481A
Authority
DK
Denmark
Prior art keywords
menerals
antigen
procedure
preparation
antigenic determinant
Prior art date
Application number
DK318481A
Other languages
English (en)
Inventor
R A Lerner
N Green
G Sutcliffe
T M Shinnick
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27389709&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK318481(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of DK318481A publication Critical patent/DK318481A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DK318481A 1980-07-17 1981-07-16 Syntetisk peptid specifik antigenisk determinant og fremgangsmaade til fremstilling af antigene meneraler deraf DK318481A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16975880A 1980-07-17 1980-07-17
US20243180A 1980-10-30 1980-10-30
US24805981A 1981-03-27 1981-03-27

Publications (1)

Publication Number Publication Date
DK318481A true DK318481A (da) 1982-01-18

Family

ID=27389709

Family Applications (1)

Application Number Title Priority Date Filing Date
DK318481A DK318481A (da) 1980-07-17 1981-07-16 Syntetisk peptid specifik antigenisk determinant og fremgangsmaade til fremstilling af antigene meneraler deraf

Country Status (15)

Country Link
EP (1) EP0044710B2 (da)
KR (1) KR870000702B1 (da)
AU (1) AU559234B2 (da)
CA (1) CA1194794A (da)
DE (1) DE3174241D1 (da)
DK (1) DK318481A (da)
ES (1) ES504033A0 (da)
FI (1) FI83662C (da)
GR (1) GR74319B (da)
IE (1) IE51410B1 (da)
IL (1) IL63224A (da)
NO (1) NO812341L (da)
NZ (1) NZ197734A (da)
PH (5) PH20629A (da)
PT (1) PT73346B (da)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US5019383A (en) * 1981-01-09 1991-05-28 New York Blood Center, Inc. Fatty acid carriers for synthetic peptides
DE3109696A1 (de) * 1981-03-13 1982-09-30 Gerhard Dr. med. 7800 Freiburg Hunsmann Verfahren zur herstellung eines als impfstoff geeigneten synthetischen peptids und es enthaltender impfstoff
DE3112338C2 (de) * 1981-03-28 1995-02-23 Klaus Von Der Helm Verwendung von Hybridisierungssonden zum Nachweis von HAV
DE3275998D1 (en) * 1981-12-22 1987-05-14 Baylor College Medicine Immunological composition and method for hepatitis b virus
ZA831547B (en) * 1982-03-15 1984-10-31 New York Blood Center Inc Fatty acid carriers for synthetic vaccines
ZA831854B (en) * 1982-03-26 1984-01-25 Biogen Nv Small peptides with the specificity of foot and mouth disease viral antigens
DE3382459D1 (de) * 1982-04-14 1991-12-19 James L Bittle Kuenstliches pikornavirusantigen.
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens
ZA836080B (en) * 1982-08-23 1984-04-25 Scripps Clinic Res Broad spectrum influenza antisera
EP0105481A1 (en) * 1982-09-30 1984-04-18 The Wellcome Foundation Limited Novel antigens and vaccines containing them
US4483793A (en) * 1982-10-04 1984-11-20 The Regents Of The University Of California Dimeric oligopeptides as heptenic epitopic sites for hepatitis
EP0120906B1 (en) * 1982-10-11 1988-09-21 National Research Development Corporation Polypeptides useful in vaccination against enteroviruses
NZ207394A (en) * 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US5242798A (en) * 1983-07-21 1993-09-07 Scripps Clinic And Research Foundation Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same
US5030565A (en) * 1983-08-17 1991-07-09 Scripps Clinic And Research Foundation Polypeptide-induced monoclonal receptors to protein ligands
JPS61500053A (ja) * 1983-09-30 1986-01-16 マサチユ−セツツ　インステイチユ−ト　オブ　テクノロジ− Ａ肝炎ウィルス配列順を表すｃＤＮＡの生成
US4615973A (en) * 1983-09-30 1986-10-07 The Rockefeller University Genetically engineered organisms expressing surface proteins of T. cruzi
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
US4599231A (en) * 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4599230A (en) * 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
AU579148B2 (en) * 1984-03-09 1988-11-17 Scripps Clinic And Research Foundation Synthetic hepatitis b virus vaccine including both t cell and b cell determinants
US4636463A (en) * 1984-04-05 1987-01-13 Scripps Clinic And Research Foundation Antibodies to human interleukin-2 induced by synthetic polypeptides
US4794168A (en) * 1984-04-24 1988-12-27 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
US4663436A (en) * 1984-04-24 1987-05-05 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
GB8432401D0 (en) * 1984-12-21 1985-02-06 Bennett C E Liver fluke antigens
GB8508685D0 (en) * 1985-04-03 1985-05-09 Minor P D Peptides
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
US4735896A (en) * 1986-03-04 1988-04-05 United Biomedical, Inc. Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions
US4772685A (en) * 1985-10-02 1988-09-20 Merck & Co., Inc. Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies
US5066783A (en) * 1986-05-20 1991-11-19 Cohen Eric A Antiviral peptides and means for treating herpes infections
US4795740A (en) * 1986-05-20 1989-01-03 Cohen Eric A Antiviral peptides and means for treating herpes infections
US4777239A (en) * 1986-07-10 1988-10-11 The Board Of Trustees Of The Leland Stanford Junior University Diagnostic peptides of human papilloma virus
DK354487A (da) * 1986-07-11 1988-01-12 Noboru Yanaihara Oncogen-relaterede peptider
WO1988010300A1 (en) * 1987-06-22 1988-12-29 Medico Labs Ag Heterologous viral peptide particle immunogens
JPH03503403A (ja) * 1987-07-06 1991-08-01 ペプチド　テクノロジー　リミテッド 生物学的に活性な分子
US5128319A (en) * 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US5055396A (en) * 1987-11-03 1991-10-08 Scripps Clinic And Research Foundation Diagnostic methods and systems for quantifying apo ai
JPH02504395A (ja) * 1988-03-29 1990-12-13 スクリップス　クリニック　アンド　リサーチ　ファウンデーション アポａｉ定量のための診断方法及び診断システム
DE3911794A1 (de) * 1989-04-11 1990-10-18 Thomae Gmbh Dr K Monoklonale antikoerper gegen rekombinaten humanen gewebeplasminogenaktivator mit definierter epitopspezifitaet, deren herstellung und deren verwendung
NZ234479A (en) * 1989-07-14 1992-03-26 Schering Corp Antagonists of gm-csf derived from the carboxyl terminus, antibodies, hybridomas and pharmaceutical compositions containing anti-idiotypic antibodies
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
US7252829B1 (en) 1998-06-17 2007-08-07 Idm Pharma, Inc. HLA binding peptides and their uses
US7611713B2 (en) 1993-03-05 2009-11-03 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide compositions
US9340577B2 (en) 1992-08-07 2016-05-17 Epimmune Inc. HLA binding motifs and peptides and their uses
US5387504A (en) * 1992-09-30 1995-02-07 Merck & Co., Inc. Monospecific antibodies and assay system for detecting stromelysin cleavage products
AU5362094A (en) * 1992-10-14 1994-05-09 Scripps Research Institute, The Methods for the detection of antigen-specific immune complexes
ES2065254B1 (es) * 1993-01-23 1995-07-16 Inmunologia & Genetica Aplic Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.
US6632613B1 (en) * 1993-06-02 2003-10-14 University Of Utah Research Foundation Compositions and kits for fluorescence polarization assay of large molecules
EP0733063B1 (en) * 1993-12-09 2003-12-17 University of Utah Research Foundation Compositions and kits for fluorescence polarization assay of large molecules
CA2274585A1 (en) * 1996-12-30 1998-07-09 Innogenetics N.V. Annexin v-binding polypeptides derived from hbsag and their uses
CA2386341A1 (en) 1999-11-18 2001-05-25 Epimmune Inc. Heteroclitic analogs and related methods
US7026443B1 (en) 1999-12-10 2006-04-11 Epimmune Inc. Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
US7462354B2 (en) 1999-12-28 2008-12-09 Pharmexa Inc. Method and system for optimizing minigenes and peptides encoded thereby
CA2818654A1 (en) 2000-10-20 2002-04-25 Como Biotech Aps Pregnancy-associated plasma protein-a2 (papp-a2)
US7244580B2 (en) * 2001-11-08 2007-07-17 The Regents Of The University Of California Epsilon immunoglobulin chain derived peptides for induction of anti-IgE antibodies
EP2508596B1 (en) 2002-02-21 2015-08-12 Institute Of Virology MN/CA IX-specific monoclonal antibodies generated from MN/CA IX-deficient mice and methods of use
EP2105447A4 (en) * 2006-12-20 2010-05-05 Shino Test Corp ANTIBODIES OF AVIAN ORIGIN CAPABLE OF SPECIFICALLY BINDING TO HUMAN HMGB1, METHOD OF IMMUNOLOGICAL DETERMINATION FOR HUMAN HMGB1, AND IMMUNOLOGICAL DETERMINATION REAGENT FOR HUMAN HMGB1
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
US10513553B2 (en) 2015-11-13 2019-12-24 Visterra, Inc. Compositions and methods for treating and preventing influenza
AU2020248404A1 (en) 2019-03-25 2021-09-30 Visterra, Inc. Compositions and methods for treating and preventing influenza

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
US4075194A (en) * 1976-12-09 1978-02-21 Yeda Research And Development Co., Ltd. Novel synthetic undecapeptide and clinical assay
NO158880C (no) * 1977-11-08 1988-11-09 Genentech Inc Fremgangsmaate for fremstilling av et spesifikt pattedyrhormon.
US4193915A (en) * 1978-04-13 1980-03-18 Mckerns Kenneth W Contraceptive, antibody generating, polypeptides
JP2530801B2 (ja) * 1978-12-22 1996-09-04 バイオゲン インコーポレイテッド 組換えｄｎａ分子
US4220565A (en) * 1979-01-18 1980-09-02 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
SE447263B (sv) * 1979-04-20 1986-11-03 Bonnierfoeretagen Ab Syntetisk, antigeniskt aktiv polypeptid och antigeniskt medel innehallande nemnda polypeptid
IE52036B1 (en) * 1979-05-24 1987-05-27 Univ California Non-passageable viruses

Also Published As

Publication number Publication date
NO812341L (no) 1982-01-18
ES8305419A1 (es) 1983-04-01
ES504033A0 (es) 1983-04-01
KR830006423A (ko) 1983-09-24
PT73346B (en) 1982-09-02
CA1194794A (en) 1985-10-08
FI83662C (fi) 1991-08-12
FI812092L (fi) 1982-01-18
PT73346A (en) 1981-08-01
EP0044710B2 (en) 1991-02-06
FI83662B (fi) 1991-04-30
NZ197734A (en) 1985-05-31
AU559234B2 (en) 1987-03-05
EP0044710A1 (en) 1982-01-27
GR74319B (da) 1984-06-22
DE3174241D1 (en) 1986-05-07
AU7283681A (en) 1982-01-21
PH20603A (en) 1987-02-24
IE811595L (en) 1982-01-17
IL63224A (en) 1985-05-31
PH20629A (en) 1987-03-06
PH20133A (en) 1986-10-02
IE51410B1 (en) 1986-12-24
EP0044710B1 (en) 1986-04-02
KR870000702B1 (ko) 1987-04-07
PH20597A (en) 1987-02-24
PH20598A (en) 1987-02-24
IL63224A0 (en) 1981-10-30

Similar Documents

Publication Publication Date Title
DK318481A (da) Syntetisk peptid specifik antigenisk determinant og fremgangsmaade til fremstilling af antigene meneraler deraf
MX7563E (es) Procedimiento para preparar un complejo inmunogeno que contiene proteinas antigenicas y peptidos
NO792822L (no) Antigen-preparat og fremgangsmaate for fremstilling derav
DK88881A (da) Fremgangsmaade til fremstilling af et protein under indsaettelse af en dexynucleotidsekvens i en transfervektor
NO944475L (no) Kombinerte vaksiner omfattende Hepatit B overflateantigen og andre antigener
DK59778A (da) Fremgangsmaade til fremstilling af antigen og antistof
JPS5786051A (en) Determination of antigen employing two or more monochronal antibodies
DK451982A (da) Fremgangsmaade og apparat til bestemmelse af antigeners tilstedevaerelse
IT1119257B (it) Procedimento e reagente per raggi immunologici
DK525080A (da) Fremgangsmaade til fremstilling af sproejtestoebte plastemner med indstoebte dekorative og eller beskrivende tryk
PT83894A (en) Monoclonal antibodies cross-reactive and cross-protective against p aeroginosa serotypes
NO302176B1 (no) Fremgangsmåte for fremstilling av et monoklonalt antistoff og et antigen
IT1197431B (it) Antigene anti-malarico, procedimento per la sua preparazione e vaccino che lo contiene
DK132779A (da) Fremgangsmaade til fremstilling af cishexahydrodibenzoepyranoner og tetrahydrobenzoxoiner
GB8304538D0 (en) Antibodies and antigens
DK557383D0 (da) Monoclone antistoffer og deres anvendelse
DK427281A (da) Fremgangsmaade til fremstilling af terapeutiske praeparater
DK228081A (da) Fremgangsmaade til isolering af virale glycoproteinantigener og dens anvendelse til fremstilling af vacciner
BE888224A (fr) Dispositif de preparation et de projection de mortiers de crepissage,
DK185988A (da) Anvendelse af antigen
JPS5244230A (en) Detection of hepatisis antigen and antibody and hepatisis vaccine
KR890700832A (ko) 그람 음성균의 항원 결정기와 결합하는 사람 단일클론성 항체
DK33181A (da) Fremgangsmaade til fremstilling af et interferonlignende protein
EP0551308A4 (en) Novel peptide antigens and immunoassays, test kits and vaccines using the same
DK340579A (da) Fremgangsmaade og apparat til fremstilling af emballerede drikkevarer

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment